Table 2.
The death rate of urethane-injected mice at the end of treatment.
| Group | Total | Survived (w/tumors) |
Survived (w/o tumors) |
Died | Death rate |
|---|---|---|---|---|---|
| WT-NC | 15 | 8 | 6 | 1 | 6.67% |
| WT-TF | 15 | 5 | 9 | 1 | 6.67% |
| WT-TH | 15 | 2 | 12 | 1 | 6.67% |
| IFNγ-/--NC | 11 | 5 | 3 | 3 | 27.27% |
| IFNγ-/--TF | 14 | 7 | 4 | 3 | 21.43% |
| IFNγ-/--TH | 12 | 6 | 3 | 3 | 25.00% |
Female wild-type and IFNγ-/- mice received the treatment as indicated in Figure 6A. Survived (w/tumors): the mice were still alive at the end of experiment but had tumors; Survived (w/o tumors): the mice were still alive at the end of experiment and had no tumors.